516: Illuminating the Science for All to See | Usama Malik, CFO, Immunomedics

Published: July 24, 2019, 11:19 p.m.

\u201cIt\u2019s the economics, the finance,\u201d says CFO Usama Malik, who quickly adds the words \u201cand the accounting\u201d to his short list of finance leader action items. Malik begins where most CFOs end\u2013with the economics behind the business model. Everything else follows, he explains. \xa0

\u201cThis role is about applying a broader lens to an entire industry and figuring out a competitive advantage,\u201d adds Malik, who, while bullish on the science behind Immunomedics\u2019 future offerings, makes clear his contention that it\u2019s the economics that will ultimately determine the company\u2019s fate.

\u201cHistorically, there have been fund-raising CFOs, operational CFOs, and strategic CFOs. \u2026 I\u2019ve now started to combine these disciplines, and the culmination of these is really advancing the role,\u201d explains Malik.\xa0\u2013Jack Sweeney\xa0\xa0\xa0